Health Resource Utilization in Patients with Advanced Non-Small Cell Lung Cancer Receiving Chemotherapy in China

[1] Soares M(2007)Prognosis of lung cancer patients with life-threatening complications Chest 131 840-846

[2] Darmon M(2009)Revisiting stage IIIB and IV non-small cell lung cancer: analysis of the surveillance, epidemiology, and end results data Chest 136 701-709

[3] Salluh JI(2015)A retrospective study of risk and prognostic factors in relation to lower respiratory tract infection in elderly lung cancer patients Am J Cancer Res 5 423-432

[4] Ferreira CG(2007)Developments in the treatment of non-small cell lung cancer Anticancer Res 27 2823-2827

[5] Thiéry G(2015)Icotinib plus gemcitabine for metastatic pancreatic cancer: a case report World J Gastroenterol 21 3441-3446

[6] Schlemmer B(2010)American Society of Clinical Oncology Clinical Practice Guideline update on chemotherapy for stage IV non-small-cell lung cancer [in Chinese] Zhongguo Fei Ai Za Zhi 13 171-189

[7] William WN(2004)Front-line paclitaxel-vinorelbine versus paclitaxel-carboplatin in patients with advanced non-small-cell lung cancer: a randomized phase III trial Ann Oncol 15 1048-1055

[8] Lin HY(2010)Recent issues in first-line treatment of advanced non-small-cell lung cancer: results of an International Expert Panel Meeting of the Italian Association of Thoracic Oncology Lung Cancer 68 319-331

[9] Lee JJ(2010)Factors affecting bone marrow toxicity following administration of carboplatin and paclitaxel in patients with non-small cell lung cancer Anticancer Res 30 1365-1369

[10] Lippman SM(2012)New strategies in squamous cell carcinoma of the lung: identification of tumor drivers to personalize therapy Clin Cancer Res 18 3002-3007

[1] Soares M(2007)Prognosis of lung cancer patients with life-threatening complications Chest 131 840-846

[2] Darmon M(2009)Revisiting stage IIIB and IV non-small cell lung cancer: analysis of the surveillance, epidemiology, and end results data Chest 136 701-709

[3] Salluh JI(2015)A retrospective study of risk and prognostic factors in relation to lower respiratory tract infection in elderly lung cancer patients Am J Cancer Res 5 423-432

[4] Ferreira CG(2007)Developments in the treatment of non-small cell lung cancer Anticancer Res 27 2823-2827

[5] Thiéry G(2015)Icotinib plus gemcitabine for metastatic pancreatic cancer: a case report World J Gastroenterol 21 3441-3446

[6] Schlemmer B(2010)American Society of Clinical Oncology Clinical Practice Guideline update on chemotherapy for stage IV non-small-cell lung cancer [in Chinese] Zhongguo Fei Ai Za Zhi 13 171-189

[7] William WN(2004)Front-line paclitaxel-vinorelbine versus paclitaxel-carboplatin in patients with advanced non-small-cell lung cancer: a randomized phase III trial Ann Oncol 15 1048-1055

[8] Lin HY(2010)Recent issues in first-line treatment of advanced non-small-cell lung cancer: results of an International Expert Panel Meeting of the Italian Association of Thoracic Oncology Lung Cancer 68 319-331

[9] Lee JJ(2010)Factors affecting bone marrow toxicity following administration of carboplatin and paclitaxel in patients with non-small cell lung cancer Anticancer Res 30 1365-1369

[10] Lippman SM(2012)New strategies in squamous cell carcinoma of the lung: identification of tumor drivers to personalize therapy Clin Cancer Res 18 3002-3007